SpaceX IPO Opens to Retail Investors via Major Brokerage Platforms Polymarket Traders Predict SpaceX OpenAI Anthropic Could Surpass Berkshire Hathaway on Public Debut MalaysiaJapan Hydrogen Project Scales Back Amid Funding Challenges April Jobs Report Preview Labor Market Cooling but Resilient Economists Anticipate US Treasury Yields Surge as RiskFree Asset Assumptions Shift Amid Geopolitical and Inflation Concerns SoFi Technologies Reports Solid Quarterly Results Amid Softer Forward Guidance YI Q3 2024 Earnings EPS Loss of 0145 Highlights Ongoing Operational Headwinds ProAssurance Q1 2026 Earnings EPS Misses Estimates Amidst Underwriting Headwinds Harmonic Inc HLIT Q1 2026 Earnings EPS Surges Past Estimates by 79 Catheter Precision Inc Q1 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises Despite Deep Loss Aspen Aerogels ASPN Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures Eagle Bancorp Montana Inc EBMT Q1 2026 Earnings Earnings Beat Driven by Solid Net Interest Margin Evolution Metals Technologies Corp EMAT Sheds 312 as Shares Approach Support at 643 Daedalus Special Acquisition Corp Unit DSACU Holds Steady at 1003 Amid Low Volatility Nuveen AMTFree Municipal Credit Income Fund NVG Edges Higher Amid Steady Trading BXP Inc Holds Steady Near 60 Support and Resistance Levels in Focus LendingTree Holds Above Support After Modest Gain Trump Calls for Totally Independent Fed Chair Signaling Shift from Pressure Tactics Intellicheck IDN Q1 2026 Earnings EPS Surges Past Estimates with 9737 Beat JELDWEN Holding Inc JELD Stages a Modest Recovery Navigating Support and Resistance Levels Propanc Biopharma PPCB Slides 69 as Weak Momentum Tests Key Support Halozyme Therapeutics HALO Rises Modestly Support and Resistance Levels in Focus Alpha Tau Medical DRTS Shows Modest Uptick Testing Key Resistance Surrozen Inc SRZN Edges Higher as Stock Tests Key Resistance Amid Low Volume Inventiva SA IVA Slides 269 as Biotech Sentiment Sours Backblaze Inc BLZE Slips 238 as Stock Tests Key Support Near 720 Vera Therapeutics VERA Consolidates Near Support After Slight Decline